News

Business
General
Money
Personal Money
Funds
Insurance
Taxes
Trading
Investment

UPDATE 2-Clovis Oncology's Rubraca data sets stage for label expansion


June 19 (Reuters) - Positive data on Clovis Oncology Inc's ovarian cancer drug, Rubraca, from a late-stage study could help the U.S. biotech widen the use of the therapy and differentiate it against rivals, the company said on Monday.

Tags:
Source:  http://feeds.reuters.com/~r/reuters/companyNews/~3/6Ydb48rCH6I/clovis-study-idUSL3N1JG2TI


More news:
December - 2017
MoTuWeThFrSaSu
    123
45678910
11121314151617
18192021222324
25262728293031
January - 2018
MoTuWeThFrSaSu
1234567
891011121314
15161718192021
22232425262728
293031    
February - 2018
MoTuWeThFrSaSu
   1234
567891011
12131415161718
19202122232425
262728